MX2012012559A - Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo. - Google Patents

Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Info

Publication number
MX2012012559A
MX2012012559A MX2012012559A MX2012012559A MX2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A MX 2012012559 A MX2012012559 A MX 2012012559A
Authority
MX
Mexico
Prior art keywords
dopamine
composition
tio2
brain
hemiparkinsonism
Prior art date
Application number
MX2012012559A
Other languages
English (en)
Inventor
Patricia Vergara Aragon
María Guadalupe Valverde Aguilar
Jorge Alfonso Garcia Macedo
Original Assignee
Patricia Vergara Aragon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patricia Vergara Aragon filed Critical Patricia Vergara Aragon
Priority to MX2012012559A priority Critical patent/MX2012012559A/es
Publication of MX2012012559A publication Critical patent/MX2012012559A/es

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición de TiO2/Dopamina preparado por el método sol-gel con nanoporos que contienen a la dopamina y la protegen de oxidación por luz y aire que la dañarían impidiendo su efecto como neurotransmisor en el cerebro. La liberación constante de la dopamina desde el composición permite un control de los síntomas del Mal de Parkinson.
MX2012012559A 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo. MX2012012559A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012012559A MX2012012559A (es) 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012012559A MX2012012559A (es) 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Publications (1)

Publication Number Publication Date
MX2012012559A true MX2012012559A (es) 2014-04-28

Family

ID=51213264

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012559A MX2012012559A (es) 2012-10-29 2012-10-29 Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.

Country Status (1)

Country Link
MX (1) MX2012012559A (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173258A1 (en) * 2014-05-13 2015-11-19 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
WO2024056749A1 (en) 2022-09-14 2024-03-21 Inbrain Pharma Pharmaceutical injectable solution comprising dopamine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015173258A1 (en) * 2014-05-13 2015-11-19 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
US10105326B2 (en) 2014-05-13 2018-10-23 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
EP3453388A1 (en) 2014-05-13 2019-03-13 Centre Hospitalier Régional et Universitaire de Lille Pharmaceutical solution comprising dopamine hydrochloride
AU2015260953B2 (en) * 2014-05-13 2020-02-27 Centre Hospitalier Regional Et Universitaire De Lille (Chru) Pharmaceutical solution comprising dopamine for use in treating Parkinson's disease
WO2024056749A1 (en) 2022-09-14 2024-03-21 Inbrain Pharma Pharmaceutical injectable solution comprising dopamine

Similar Documents

Publication Publication Date Title
IL285922A (en) Interneuronal cells of the cerebral cortex and other neurons produced by direct differentiation of pluripotent and multipotent cells
IL267997A (en) Preparations, formulations and methods for treating eye diseases
EP2863910A4 (en) COMPOSITIONS AND METHOD FOR REGULATING GLUCOSE-HOMOSTOSTASE AND INSULIN EFFECT
HK1214168A1 (zh) 通過控制血糖水平用於治療糖尿病及相關疾病的組合物、方法以及用途
MY179194A (en) Process for preparing therapeutic nanoparticles
EP2931288A4 (en) TOPICAL FORMULATIONS FOR INCREASING THE DERMAL CONCENTRATION OF HYALURONIC ACID
PL2882779T3 (pl) Pochodna kwasu hialuronowego, sposób jej wytwarzania, sposób jej modyfikacji i jej zastosowanie
IL230635A (en) An outgrowth of 4,3,2,1-tetrahydroquinoline used to treat diabetes
EP2861224A4 (en) EPINHEPHRINE NANOPARTICLES, PROCESS FOR THEIR MANUFACTURE AND METHODS OF USE THEREOF FOR THE TREATMENT OF EPINEPHRINE-RESPONSIBLE DISORDERS
SG11201404728VA (en) Nanoparticle paste formulations and methods for production and use thereof
IN2015DN00924A (es)
HK1206016A1 (en) Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions ep4 ep4
GB2518801B (en) Improvements in, or relating to, caskets or coffins
HK1215794A1 (zh) 用於治療疾病的同種異體自噬體富集組合物
MX363385B (es) Métodos para el tratamiento de enfermedad de células falciformes y otras condiciones inflamatorias.
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
MX2012012559A (es) Composicion de tio2/dopamina implantada en el cerebro de la rata para el tratamiento del hemiparkinsonismo.
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
ZA201408065B (en) Compositions and methods for the treatment of diabetes
MX2013007331A (es) Composicion de tio2/15c5/dopamina insertada en el cerebro de la rata para el tratamiento de hemiparkinsonismo.
WO2013038195A3 (en) Pharmaceutical nanoparticle compositions
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.
PL2834030T3 (pl) Sposób wytwarzania wyciskanego czopa korbowego
IN2012CH02984A (es)
TR201204300A2 (tr) Esomeprazol içeren tablet formülasyonlarının üretimine ilişkin yöntem.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal